Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori

Cancer

Volumn 80, Issue 10, 1997, Pages 1897-1903

  Zhang, Hui Min ^a   Wakisaka, Noriko ^a   Maeda, Osamu ^a   Yamamoto, Tatsuo ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

Gastric carcinoma prevention; Helicobacter pylori; Minimum inhibitory concentration; Mongolian gerbil; Vitamin C

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ISOASCORBIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; GASTRITIS; GERBIL; HELICOBACTER PYLORI; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANIMALS; ASCORBIC ACID; GASTRIC MUCOSA; GERBILLINAE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0030670376     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971115)80:10<1897::AID-CNCR4>3.0.CO;2-L     Document Type: Article

References (28)

1. Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1: 1273-5.
2. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
3. Parsonnet J, Freidman GD, Daniel MS, Vandersteen DP, Chang Y, Vogelman JH, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325: 1127-31.
4. Buiatti E, Palli D, Decarli A, Amadori D, Avellini C, Bianchi S, et al. A case-control study of gastric cancer and diet in Italy. II. association with nutrients. Int J Cancer 1990;45:896-901.
5. Mirvish SS. Effects of vitamin C and E on N-nitroso compound formation, carcinogenesis and cancer. Cancer 1986;58:1842-50.
6. Hemilä H, Roberts P, Wikström M. Activated polymorphonuclear leucocytes consume vitamin C. FEBS Lett 1984;178: 25-30.
7. Sobala GM, Schorah CJ, Shires S, Lynch DA, Gallacher B, Dixon MF, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993;34: 1038-41.
8. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci 1995;40:615-21.
9. Marshall BJ, Royce H, Annear DI, Goodwin CS, Pearman JW, Warren JR, et al. Original isolation of Campylobacter pyloridis from human gastric mucosa. Microbios Lett 1984;25:83-8.
10. Japan Society of Chemotherapy. Committee report. Chemotherapy 1981;29:76-9.
11. Hirayama F, Takagi S, Yokoyama Y, Iwao E, Ikeda Y. Establishment of gastric Helicobacter pylori infection in Mongolian gerbils. J. Gastroenterol 1996;31(Suppl IX):24-8.
12. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokoyama Y, Ikeda Y. Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 1996;31:755-7.
13. The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993;341:1359-62.
14. Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, et al. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research group on prevention of gastric carcinoma among young adults. Cancer 1995;75:2789-93.
15. Endo S, Ohkusa T, Saito Y, Fujiki K, Okayasu I, Sato C. Detection of Helicobacter pylori infection in early stage gastric cancer: a comparison between intestinal-and diffuse-type gastric adenocarcinomas. Cancer 1995;75:2203-8.
16. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 1994;73:2691-4.
17. Coggon D, Acheson ED. The geography of cancer of the stomach. Br Med Bull 1984;40:335-41.
18. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaka T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
19. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
20. Singh VN, Gaby SK. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation. Am J Clin Nutr 1991;53(1 Suppl): 386S-90S.
21. Cohen M, Bhagavan HN. Ascorbic acid and gastrointestinal cancer. J Am Coll Nutr 1995;14:565-78.
22. Drake IM, Davies MJ, Mapstone NP, Dixon MF, Schorah CJ, White KL, et al. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis 1996;17:559-62.
23. Meyers DG, Maloley PA, Weeks D. Safety of antioxidant vitamins. Arch Intern Med 1996;156:925-35.
24. Nilius M, Bode G, Lehnhardt G, Malfertheiner P. In vitro inhibition of Helicobacter pylori urease: biochemical and ultrastructural analysis. Eur J Clin Invest 1991;21:551-7.
25. Ødum L. pH optimum of the reduction of dehydroascorbic acid by dithioerytritol. Scand J Clin Lab Invest 1993;53:367-71.
26. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KE. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994;35:317-22.
27. Ødum L, Andersen LP. Investigation of Helicobacter pylori ascorbic acid oxidating activity. FEMS Immunol Med Microbiol 1995;10:289-94.
28. Talley NJ, Ormand JE, Frie CA, Zinsmeister A. Stability of pH gradients in vivo across the stomach in Helicobacter pylori gastritis, dyspepsia and health. Am J Gastroenterol 1992;87: 590-4.